ROSS ROBERT W.
Insider CIK 1733077 · SURF Chief Medical Officer, Director · XLO Director · OBX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OBX Obsidian Therapeutics, Inc | A Award deriv | 2026-08-03 | 2026-08-05 | 37,653 | — | $0 | 37,653 | SEC↗ |
| OBX Obsidian Therapeutics, Inc | A Award deriv | 2026-08-03 | 2026-08-05 | 37,653 | — | $0 | 37,653 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 31,000 | — | $0 | 31,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2024-06-14 | 2024-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SURF Surface Oncology, Inc. | D To issuer deriv | 2023-09-08 | 2023-09-08 | 400,000 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | D To issuer | 2023-09-08 | 2023-09-08 | 83,193 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2023-08-01 | 2023-08-11 | 16,713 | $0.94 | $15.7K | 83,193 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2023-06-12 | 2023-06-13 | 13,200 | — | $0 | 13,200 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 400,000 | — | $0 | 400,000 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2022-08-03 | 2022-08-05 | 10,594 | $1.72 | $18.2K | 99,906 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 26,400 | — | $0 | 26,400 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 359,000 | — | $0 | 359,000 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award | 2022-03-01 | 2022-03-03 | 56,000 | — | $0 | 110,500 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2021-07-21 | 2022-01-14 | 33,500 | $6.10 | $204.3K | 54,500 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2021-02-16 | 2021-02-18 | 1,000 | $11.35 | $11.3K | 88,000 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2021-02-12 | 2021-03-03 | 484,280 | — | $0 | 484,280 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2021-02-12 | 2021-03-11 | 484,280 | — | $0 | 484,280 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2021-01-15 | 2021-01-15 | 2,000 | $12.25 | $24.5K | 89,000 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2021-01-14 | 2021-01-15 | 7,000 | $11.95 | $83.7K | 91,000 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2020-12-15 | 2020-12-17 | 1,000 | $10.48 | $10.5K | 98,000 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2020-12-11 | 2020-12-15 | 1,405 | $10.05 | $14.1K | 99,000 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2020-11-11 | 2020-11-13 | 595 | $10.05 | $6.0K | 100,405 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2020-10-14 | 2020-10-16 | 4,000 | $10.05 | $40.2K | 101,000 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2020-02-03 | 2020-02-05 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award | 2020-02-03 | 2020-02-05 | 80,000 | — | $0 | 105,000 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2019-03-01 | 2019-03-04 | 90,000 | — | $0 | 90,000 | SEC↗ |
| SURF Surface Oncology, Inc. | M Exercise deriv | 2019-01-04 | 2019-01-08 | 25,000 | — | $0 | 256,578 | SEC↗ |
| SURF Surface Oncology, Inc. | M Exercise | 2019-01-04 | 2019-01-08 | 25,000 | $4.14 | $103.5K | 25,000 | SEC↗ |